Anagrelid: Thromboserisiko einschliesslich Hirninfarkt nach abruptem Absetzen der Behandlung | Zendy

AI Assistant Blog Pricing

Open Access

Anagrelid: Thromboserisiko einschliesslich Hirninfarkt nach abruptem Absetzen der Behandlung

Author(s) -

Takeda Pharma AG

Publication year - 2022

Publication title -

schweizerische ärztezeitung

Language(s) - German

Resource type - Journals

eISSN - 1424-4004

pISSN - 0036-7486

DOI - 10.4414/saez.2022.20722

Subject(s) - gynecology , medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.